全球临床试验（最近登记）
最近登记
| 试验名称 | 登记号 | 相关药物 | 申报企业 | 招募状态 | 试验分期 | 研究类型 | 适应症 | 招募人数 | 登记日期 |
|---|---|---|---|---|---|---|---|---|---|
| Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes | NCT07797036 | Drug: Semaglutide (Wegovy) weekly injection | University of Massachusetts, Worcester | NOT_YET_RECRUITING | PHASE2、PHASE3 | INTERVENTIONAL | Gestational Diabetes Mellitus (GDM)、Metabolic Syndrome | 226 (ESTIMATED) | 2026-09-01 |
| Vaginal Examination Drape Supporting Women's Privacy | NCT07797309 | Device: Privacy-supporting vaginal examination drape | KTO Karatay University | ENROLLING_BY_INVITATION | NA | INTERVENTIONAL | Gynecologic Examination、Pain、Patient Satisfaction、Privacy | 100 (ESTIMATED) | 2026-09-01 |
| Full-Body and Lower-Limb Stretching on Explosive Power and Agility | NCT07796464 | — | China Medical University Hospital | RECRUITING | — | OBSERVATIONAL | Static Stretching | 60 (ESTIMATED) | 2026-09-01 |
| Impact of Mirror Therapy Combined With Conventional Training on Gait and Lower Limb Motor Function Among Post-Stroke Patients | NCT07797712 | Other: Mirror Therapy Based Functional Training、Other: Conventional Lower Limb Training | Ibadat International University, Islamabad | RECRUITING | NA | INTERVENTIONAL | Stroke | 52 (ESTIMATED) | 2026-09-01 |
| The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition | NCT07796776 | — | IRCCS San Raffaele | ACTIVE_NOT_RECRUITING | — | OBSERVATIONAL | Inclusion Body Myositis (IBM)、Motor Neuron Disease, Amyotrophic Lateral Sclerosis | 30 (ESTIMATED) | 2026-09-01 |
| Phase 1 Study to Evaluate the Safety and Drug-Drug Interactions in Healthy Adult Participants | NCT07797621 | Drug: AG2203L、Drug: AG2203E、Drug: AG2203L+AG2203E | Ahn-Gook Pharmaceuticals Co.,Ltd | COMPLETED | PHASE1 | INTERVENTIONAL | Acute Bronchitis | 36 (ACTUAL) | 2026-09-01 |
| Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone as First-Line Maintenance Therapy in Ovarian Cancer Overexpressing Cyclin E1 | NCT07797283 | Drug: INCB123667、Drug: Bevacizumab、Drug: Placebo | Incyte Corporation | NOT_YET_RECRUITING | PHASE3 | INTERVENTIONAL | Ovarian Cancer | 590 (ESTIMATED) | 2026-09-01 |
| Optimizing Gait Rehabilitation After Stroke | NCT07798388 | Other: VR-feedback application | University Hospital, Ghent | NOT_YET_RECRUITING | NA | INTERVENTIONAL | Stroke Gait Rehabilitation | 93 (ESTIMATED) | 2026-09-01 |
| Perioperative Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection | NCT07796451 | Device: Active Low-Frequency Repetitive Transcranial Magnetic Stimulation、Device: Sham Repetitive Transcranial Magnetic Stimulation | The First Affiliated Hospital of Guangzhou Medical University | NOT_YET_RECRUITING | PHASE2 | INTERVENTIONAL | Sleep Wake Disorders、Lung Neoplasms | 220 (ESTIMATED) | 2026-09-01 |
| A Study of RT023 in Patients With Advanced Solid Tumors | NCT07797426 | Drug: RT023 | Shanghai Ruotuo Biosciences Co., Ltd. | NOT_YET_RECRUITING | PHASE1、PHASE2 | INTERVENTIONAL | Advanced Malignant Solid Tumours | 318 (ESTIMATED) | 2026-09-01 |